Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,124.4
10.5 (0.34%)

 

  • STI Straits Times Index
    3,124.4
    10.5 (0.34%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,567.6
    10.8 (0.69%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,521.8
    213.4 (0.81%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,007.9
    34.2 (1.15%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,798.9
    246.9 (1.15%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,126.9
    21.1 (0.35%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,067.4
    22.8 (1.11%)
    Index delayed 20 minutes
  • XAO XAO
    6,757.9
    36.0 (0.54%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 769.7M
  • Value: 810.8M
  • Rise: 153
  • Fall: 154
  • Unch: 526

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.079-0.003
Singapore-eDev0.047+0.002
Y Ventures0.112-0.026
Alpha Energy0.025-0.003
Genting Sing0.915+0.005
SunMoonFood^0.057-0.002
Spackman0.013-
Synagie0.136-0.002
TEE Intl0.046-0.001
Golden Agri-Res0.210-

World Indices

World Indices
Name Last Change
Nasdaq 7,950.8 +47.0
HSI 26,521.8 +213.4
HSCEI 10,507.9 +55.3
Jakarta 6,126.9 +21.1
Nikkei 225 21,798.9 +246.9
SSE Comp 3,007.9 +34.2
Shanghai A 3,151.2 +35.9
Shanghai B 271.1 +2.0
PSE Comp 0.0
KOSPI 2,067.4 +22.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

News - Detailed News Story

Lonza: Sign Contract To Manufacture Remsima Drug Substance With Celltrion.

03 Sep 2019 10:42

Celltrion contracts Remsima drug substance manufacturing to Lonza to satisfy increasing global demand for biosimilars. Lonza's biologics facility in Singapore to cover EU and US market needs. Partnership will provide cost-effective biologics for greater patient benefit worldwide...

Attachments: Source: ShareInvestor Express
Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.